Figures & data
Figure 1. Structures of hesperidin and its derivatives. Hesperidin (1): a 1:1 mixture of 2 and 3; hesperetin (4): a 1:1 mixture of 5 and 6; glucosyl hesperidin (7): a 1:1 mixture of 8 and 9.
Figure 2. Protective effects of hesperidin (1), hesperetin (4), and glucosyl hesperidin (7) on (a) RNase A targeted by methyglyoxal (MGO) attack. (b) Advanced glycation end-products (AGEs) formation between bovine serum albumin (BSA) and glucose. The concentrations of tested samples and aminoguanidine (AG) were 1 mM. Each value was expressed as the mean ± SD, n = 3.
Figure 3. Protective effects of hesperidin (1), (2S)-hesperidin (2), and (2R)-hesperidin (3) on (a) RNase A targeted by methyglyoxal (MGO) attack. (b) Advanced glycation end-products (AGEs) formation between bovine serum albumin (BSA) and glucose. The concentrations of tested samples and aminoguanidine (AG) were 1 mM. Each value was expressed as the mean ± SD, n = 3.
Figure 4. Protective effects of hesperetin (4), (2S)-hesperetin (5), and (2R)-hesperetin (6) on (a) RNase A targeted by methyglyoxal (MGO) attack. (b) Advanced glycation end-product (AGE) formation between bovine serum albumin (BSA) and glucose. The concentrations of tested samples and aminoguanidine (AG) were 1 mM. Each value was expressed as the mean ± SD, n = 3.
